Tehrani Lily, Tashjian Michelle, Mayrovitz Harvey N
Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA.
Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Davie, USA.
Cureus. 2025 Mar 13;17(3):e80510. doi: 10.7759/cureus.80510. eCollection 2025 Mar.
Microneedling (MN), also known as percutaneous collagen induction therapy, is a minimally invasive dermatologic procedure that stimulates the skin's intrinsic wound repair cascade by creating controlled micro-injuries to the epidermis and dermis using multiple small-sized needles. This review aims to document and discuss the skin's physiological mechanisms activated through the MN process and its therapeutic applications and, where possible, to describe the impacts on changes in the skin's biophysical properties. Three databases, namely, PubMed, Web of Science, and Embase, were searched for relevant peer-reviewed articles published in English between 1990 and 2024. After eliminating duplicate and irrelevant articles, 70 studies were included in this review. The main physiological mechanisms associated with the MN process were collagen and elastin production, angiogenesis, transient increases in skin permeability, and improved epidermal barrier function post-treatment. Therapeutic applications targeted cosmetic improvements, scar healing, and drug delivery. As the wound repair process is initiated, fibroblasts migrate to the wounded area to initiate collagen and elastin production, contributing to the improved firmness and elasticity of the healed epidermis. The micropores created by MN increase skin permeability, allowing hydrophilic water-soluble molecules to transfer across the skin to enhance transdermal drug delivery and absorption. Multiple growth factors are secreted by monocytes upon injury and contribute to collagen production, epithelization, and angiogenesis, which increase epidermal thickness and epidermal barrier enhancement found post-procedure. Additionally, TGFM-1, a cross-linker of the protein filaggrin, and ki67, a marker of cell proliferation, are upregulated following the controlled tissue injury. These upregulated biomarkers contribute to the increase in filaggrin and the improvement of skin barrier function. Ceramides, which help retain moisture and prevent transepidermal water loss, are also increased when MN is combined with a solution containing human adipose tissue stem cell-derived exosomes. The cosmetic applications included improvements in skin texture, wrinkles, and scarring. As a minimally invasive procedure, MN is reported to have a low risk of post-procedural hyperpigmentation, scarring, or other adverse effects.
微针疗法(MN),也称为经皮胶原诱导疗法,是一种微创皮肤科手术,通过使用多个小尺寸针头对表皮和真皮造成可控的微损伤,刺激皮肤自身的伤口修复级联反应。本综述旨在记录和讨论通过微针疗法激活的皮肤生理机制及其治疗应用,并在可能的情况下描述对皮肤生物物理特性变化的影响。检索了三个数据库,即PubMed、科学网和Embase,以查找1990年至2024年期间发表的相关英文同行评审文章。在剔除重复和不相关的文章后,本综述纳入了70项研究。与微针疗法相关的主要生理机制包括胶原蛋白和弹性蛋白的产生、血管生成、皮肤通透性的短暂增加以及治疗后表皮屏障功能的改善。治疗应用针对美容改善、疤痕愈合和药物递送。随着伤口修复过程的启动,成纤维细胞迁移到受伤区域以启动胶原蛋白和弹性蛋白的产生,有助于改善愈合表皮的紧致度和弹性。微针疗法产生的微孔增加了皮肤通透性,使亲水性水溶性分子能够穿过皮肤转移,以增强透皮药物递送和吸收。单核细胞在受伤时会分泌多种生长因子,有助于胶原蛋白的产生、上皮形成和血管生成,这些增加术后发现的表皮厚度增加和表皮屏障增强。此外,在可控组织损伤后,角蛋白丝聚集蛋白的交联剂转化生长因子-β1(TGFM-1)和细胞增殖标志物Ki67会上调。这些上调的生物标志物有助于角蛋白丝聚集蛋白的增加和皮肤屏障功能的改善。当微针疗法与含有人类脂肪组织干细胞衍生外泌体的溶液联合使用时,有助于保持水分并防止经表皮水分流失的神经酰胺也会增加。美容应用包括改善皮肤质地、皱纹和疤痕。作为一种微创手术,据报道微针疗法术后出现色素沉着过度、疤痕或其他不良反应的风险较低。